C07K 7/04
Linear peptides containing only normal peptide links
C07K7/04 (Linear peptides containing only normal peptide links) appears on 8,561 US grants and 11,387 published applications in this corpus.
Search patents in C07K- Granted patents
- 8,561
- Published applications
- 11,387
- Assignees
- 4,033
- Inventors
- 19,083
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 19 | 0 |
| 1977 | 23 | 0 |
| 1978 | 29 | 0 |
| 1979 | 7 | 0 |
| 1980 | 28 | 0 |
| 1981 | 18 | 0 |
| 1982 | 17 | 0 |
| 1983 | 34 | 0 |
| 1984 | 43 | 0 |
| 1985 | 33 | 0 |
| 1986 | 30 | 0 |
| 1987 | 48 | 0 |
| 1988 | 33 | 0 |
| 1989 | 36 | 0 |
| 1990 | 22 | 0 |
| 1991 | 40 | 0 |
| 1992 | 50 | 0 |
| 1993 | 44 | 0 |
| 1994 | 40 | 0 |
| 1995 | 73 | 0 |
| 1996 | 83 | 0 |
| 1997 | 128 | 0 |
| 1998 | 191 | 0 |
| 1999 | 132 | 0 |
| 2000 | 114 | 0 |
| 2001 | 146 | 14 |
| 2002 | 133 | 162 |
| 2003 | 142 | 327 |
| 2004 | 140 | 253 |
| 2005 | 104 | 310 |
| 2006 | 168 | 313 |
| 2007 | 162 | 250 |
| 2008 | 170 | 280 |
| 2009 | 186 | 329 |
| 2010 | 195 | 416 |
| 2011 | 198 | 387 |
| 2012 | 199 | 354 |
| 2013 | 318 | 525 |
| 2014 | 379 | 599 |
| 2015 | 402 | 616 |
| 2016 | 444 | 621 |
| 2017 | 447 | 612 |
| 2018 | 439 | 574 |
| 2019 | 493 | 614 |
| 2020 | 472 | 670 |
| 2021 | 432 | 637 |
| 2022 | 394 | 596 |
| 2023 | 306 | 548 |
| 2024 | 327 | 549 |
| 2025 | 278 | 471 |
| 2026 | 172 | 360 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Engineered cells and uses thereof6 Oct 2026US 12,751,929 B2Ohio State Innovation Foundation
- Peptide libraries with non-canonical amino acids6 Oct 2026US 12,753,205 B2Regeneron Pharmaceuticals, Inc.
- Pharmaceutical composition for treatment or prevention of ischemic cardiovascular disease29 Sep 2026US 12,746,220 B2Industry-Academic Cooperation Foundation, Yonsei University
- Self-assembling peptides and hydrogels29 Sep 2026US 12,747,264 B2University of Virginia Patent Foundation
- FOXM1-derived peptide, and vaccine including same29 Sep 2026US 12,747,265 B2Oncotherapy Science, Inc.
- Therapeutic peptides8 Oct 2026US 2026/0308201 A1Shape Therapeutics Inc.
- Using vefg165 fragments as a novel biomarker of inflammation to diagnose and guide medical care and treatments8 Oct 2026US 2026/0308202 A1Children's Medical Center Corporation
- P53 activator peptidomimetic macrocycles8 Oct 2026US 2026/0308203 A1Agency for Science, Technology and Research
- Primate carbonic anhydrase iv binding peptides and aavs1 Oct 2026US 2026/0294834 A1California lnstitute of Technology
- Neu5gc-lewis a-targeting molecules and uses thereof in cancer1 Oct 2026US 2026/0295060 A1SRI International
Most cited
By later US patents
- Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof1,998US 5,143,854 AAffymax Technologies N.V. · 1992
- Array of oligonucleotides on a solid substrate1,585US 5,445,934 AAffymax Technologies N.V. · 1995
- Arrays of materials attached to a substrate1,410US 5,744,305 AAffymetrix, Inc. · 1998
- Very large scale immobilized polymer synthesis967US 5,424,186 AAffymax Technologies N.V. · 1995
- Method of detecting nucleic acids962US 5,800,992 A1998